Pennant Group Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $1.1B+58.5% YoYTTM through 30 Jun 2026
Net Income $32.3M+43.3% YoYTTM through 30 Jun 2026
Free Cash Flow $34.7MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| EBITDA Margin | 6.6% |
| Operating Margin | 5.5% |
| Net Margin | 2.9% |
Returns
9.0%ROE
3.5%ROA
7.6%ROIC
Balance Sheet Health
Debt / Equity0.46x
Current Ratio1.14x
Net Debt$156.8M
Cash & Equivalents$15.3M
Quality Metrics
Altman Z-Score2.74
Piotroski F-Score6 / 9
FCF Margin3.1%
Rule of 4010.3
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2025: $947.7M
Diluted EPS$0.91TTMFY2025: $0.84
Dividend
No dividend
Capital Allocation
Capex Intensity1.7%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Home Health and Hospice Services | $732.7M | +41.0% | View detailsContinued expansion in the Southeast and integration of acquired operations from UnitedHealth and Amedisys. |
| Senior Living Services | $215M | +22.3% | View detailsFocus on same-store occupancy improvements and rate optimization. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.